HM Pinedo

1.5k total citations
20 papers, 1.3k citations indexed

About

HM Pinedo is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, HM Pinedo has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in HM Pinedo's work include Drug Transport and Resistance Mechanisms (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Biochemical and Molecular Research (3 papers). HM Pinedo is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Biochemical and Molecular Research (3 papers). HM Pinedo collaborates with scholars based in Netherlands and United States. HM Pinedo's co-authors include Giuseppe Giaccone, Henk M.W. Verheul, Judah Folkman, Epie Boven, J. Lankelma, Klaas Hoekman, A.H. Honkoop, S. C. Linn, Godefridus J. Peters and H J Broxterman and has published in prestigious journals such as The Lancet, British Journal of Cancer and Cancer and Metastasis Reviews.

In The Last Decade

HM Pinedo

20 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
HM Pinedo 691 567 252 147 119 20 1.3k
NH Mulder 644 0.9× 510 0.9× 84 0.3× 130 0.9× 130 1.1× 58 1.1k
J F Holland 664 1.0× 421 0.7× 197 0.8× 123 0.8× 243 2.0× 49 1.3k
Peter Ang 730 1.1× 469 0.8× 214 0.8× 70 0.5× 225 1.9× 57 1.6k
R Plagne 560 0.8× 282 0.5× 145 0.6× 140 1.0× 144 1.2× 100 1.3k
Lorrin Yee 514 0.7× 446 0.8× 101 0.4× 134 0.9× 128 1.1× 37 1.0k
M. Lehnert 702 1.0× 361 0.6× 106 0.4× 66 0.4× 154 1.3× 40 1.1k
Franklin C. Harwood 547 0.8× 919 1.6× 144 0.6× 180 1.2× 168 1.4× 17 1.4k
Von Hoff 540 0.8× 295 0.5× 100 0.4× 121 0.8× 171 1.4× 39 1.1k
Els O. Witteveen 536 0.8× 434 0.8× 178 0.7× 42 0.3× 158 1.3× 23 1.1k
Joanne Halsey 1.1k 1.6× 667 1.2× 145 0.6× 93 0.6× 298 2.5× 32 1.7k

Countries citing papers authored by HM Pinedo

Since Specialization
Citations

This map shows the geographic impact of HM Pinedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HM Pinedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HM Pinedo more than expected).

Fields of papers citing papers by HM Pinedo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by HM Pinedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HM Pinedo. The network helps show where HM Pinedo may publish in the future.

Co-authorship network of co-authors of HM Pinedo

This figure shows the co-authorship network connecting the top 25 collaborators of HM Pinedo. A scholar is included among the top collaborators of HM Pinedo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with HM Pinedo. HM Pinedo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baars, Arnold, et al.. (2001). Adjuvant Treatment of Colorectal Cancer: Towards Tumor-specific Immunotherapies. Cancer and Metastasis Reviews. 20(1-2). 101–108. 4 indexed citations
2.
Boven, Epie, HM Pinedo, P Scheffer, et al.. (1998). Characterization of human soft-tissue sarcoma xenografts for use in secondary drug screening. British Journal of Cancer. 78(12). 1586–1593. 8 indexed citations
3.
Ark-Otte, J van, et al.. (1998). Determinants of CPT-11 and SN-38 activities in human lung cancer cells. British Journal of Cancer. 77(12). 2171–2176. 81 indexed citations
4.
Boven, Epie, et al.. (1998). The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenografts. British Journal of Cancer. 78(12). 1600–1606. 29 indexed citations
5.
Boer, Fransien de, et al.. (1998). Changes in L-selectin expression on CD34-positive cells upon cryopreservation of peripheral blood stem cell transplants. Bone Marrow Transplantation. 22(11). 1103–1110. 34 indexed citations
6.
Honkoop, A.H., S. C. Linn, Giuseppe Giaccone, et al.. (1998). Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. British Journal of Cancer. 77(4). 621–626. 144 indexed citations
7.
Pinedo, HM, et al.. (1998). Involvement of platelets in tumour angiogenesis?. The Lancet. 352(9142). 1775–1777. 281 indexed citations
8.
Linn, S. C., A.H. Honkoop, Klaas Hoekman, et al.. (1996). p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer. British Journal of Cancer. 74(1). 63–68. 91 indexed citations
9.
Smitskamp-Wilms, Evelien, Giuseppe Giaccone, HM Pinedo, Bernard F. A. M. van der Laan, & Godefridus J. Peters. (1995). DT-diaphorase activity in normal and neoplastic human tissues; an indicator for sensitivity to bioreductive agents?. British Journal of Cancer. 72(4). 917–921. 57 indexed citations
10.
Ogilvie, Aernout C., et al.. (1994). A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2. British Journal of Cancer. 69(3). 596–598. 15 indexed citations
11.
Broxterman, H J, HM Pinedo, N Feller, et al.. (1993). Cortisol is transported by the multidrug resistance gene product P-glycoprotein. British Journal of Cancer. 67(2). 284–289. 124 indexed citations
12.
Dercksen, M. W., Klaas Hoekman, R. Dubbelman, et al.. (1993). Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours. British Journal of Cancer. 68(5). 996–1003. 11 indexed citations
13.
14.
Boven, Epie, et al.. (1993). The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer. British Journal of Cancer. 68(1). 52–56. 101 indexed citations
15.
Peters, Godefridus J., et al.. (1992). In vitro and in vivo studies on the combination of Brequinar sodium (DUP-785; NSC 368390) with 5-fluorouracil; effects of uridine. British Journal of Cancer. 65(2). 229–233. 31 indexed citations
16.
Haisma, Hidde J., et al.. (1992). A monoclonal antibody-β-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer. British Journal of Cancer. 66(3). 474–478. 82 indexed citations
17.
Wagstaff, John, et al.. (1992). Lobular panniculitis after subcutaneous administration of interleukin-2 (IL-2), and its exacerbation during intravenous therapy with IL-2. British Journal of Cancer. 66(4). 698–699. 6 indexed citations
18.
Schuurhuis, GJ, et al.. (1990). The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance. British Journal of Cancer. 62(4). 591–594. 58 indexed citations
19.
Pinedo, HM, et al.. (1990). Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells. British Journal of Cancer. 62(1). 85–88. 29 indexed citations
20.
Peters, Godefridus J., et al.. (1989). Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes. British Journal of Cancer. 59(3). 327–334. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by NH Mulder Breakdown of academic impact, for papers by J F Holland Breakdown of academic impact, for papers by Peter Ang Breakdown of academic impact, for papers by R Plagne Breakdown of academic impact, for papers by Lorrin Yee Breakdown of academic impact, for papers by M. Lehnert Breakdown of academic impact, for papers by Franklin C. Harwood Breakdown of academic impact, for papers by Von Hoff Breakdown of academic impact, for papers by Els O. Witteveen Breakdown of academic impact, for papers by Joanne Halsey
Rankless by CCL
2026